Olanzapine Market Size by Top Companies, Regions, Types and Application, End Users and Forecast to 2028
The Olanzapine Market is expected to be around US$ 2 by 2028 at a 2.1% CAGR by 2028.
Market Research Engine has published a new report titled as “Olanzapine Market by Application (Bipolar Disorder, Others and Schizophrenia), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacies, Drug stores and Retail Pharmacies and Online Providers) and Geography (North America, Europe, APAC, and RoW) – Forecast to 2023 – 2028.”
Browse Full Report: https://www.marketresearchengine.com/olanzapine-market
Olanzapine is an oral tablet used in the treatment of depression, schizophrenia and bipolar I disorder. It is available as an orally disintegrating tablet which dissolves quickly in the mouth and a tablet. The side effects related to olanzapine are difficulty in swallowing, dizziness, headache, feeling tired or restless, and drowsiness. Olanzapine is also used along with fluoxetine for the treatment of depression in adults and children at least 10 years old who have bipolar I disorder. Expansion of the olanzapine market size is propelled by surge in the population with schizophrenia of several nations, such as China and Japan. As the global population rise, individuals do not get complete nutrition for kids, which result in increase in occurrence of schizophrenia. Apart from this, the rise in government support for healthcare infrastructure advances further fuels the olanzapine market growth. Additionally, growth in the dysfunctional behavior among people contributes toward the expansion of the market. However, the adverse affects of the drugs used by people may hamper the market growth.
The Olanzapine Market is expected to be around US$ 2 by 2028 at a 2.1% CAGR by 2028.
The Olanzapine Market has been segmented as below:
Olanzapine Market by Application
- Bipolar Disorder
- Others
- Schizophrenia
Olanzapine Market by Route of Administration
- Oral
- Parenteral
Olanzapine Market by Distribution Channel
- Hospital Pharmacies
- Drug stores and Retail Pharmacies
- Online Providers
Olanzapine Market by Geography
- North America
- Europe
- Asia Pacific
- Rest of the World
On the basis of application, the market for Olanzapine is classified into Bipolar Disorder, Others and Schizophrenia. The Schizophrenia segment type is anticipated to hold the greatest share in the market. The factor which propels the growth of the segment is an increase in incidences of mental illness. For example, as per the National Institute of Mental Health (NIH) in the U.S., 52.9 million adults lived with mental illness in 2020. Therefore, a rise in incidences of mental illness, which needs olanzapine medication as a treatment to treat the disease, accelerates market growth.
Further, the market is based on Route of Administration, which is furcated into Oral and Parenteral. Compared to parenteral the oral route of administration segment is having the significant share in the market. This can be ascribed to the increased adoption of oral drugs owing to high patient compliance, noninvasive, convenient to handle, and not needing any specific sterile conditions. For example, the Sun Pharmaceutical Industries Ltd. provides oral olanzapine tablets.
Based on the market for distribution channel, the market is segmented into Hospital Pharmacies, Drug stores and Retail Pharmacies and Online Providers. The Drug stores and Retail Pharmacies are projected to capture the maximum share in the market. The easy availability of olanzapine drugs in the Drug stores and Retail Pharmacies is the key reason for the segment growth.
As per the geographical analysis, the olanzapine market is segregated as North America, Europe, Asia Pacific and Rest of the World. North America has the significant share in the market. This is owing to the universal usage of the product by patients in the region and leading manufacturers creating the product in the region.
Globally, the incidence of bipolar treatment is a vital driver of the olanzapine market growth. There is no exact medication available for the olanzapine disorder. Factors such as disturbing thoughts, loss of interest in life, abnormal emotions are few of the symptoms of olanzapine. These disorders are same to depression. The more availability of bipolar treatment is fueling more demand for the global olanzapine market. Therefore, it fuels the global olanzapine market growth.
Few notable vendors of the olanzapine market are Alkermes, Inc., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Aurobindo Pharma Ltd, Eli Lilly and Company, apotex inc., Dr. Reddy’s Laboratories Ltd., Torrent Group, Novartis AG, and Viatris
Henceforth, the schizophrenia, bipolar and other mental disorders are considered as a serious condition across the world, regardless of age, gender and other factors. There is no proper treatment for these conditions but, the olanzapine is considered to have to have significant role in controlling the symptoms of mental disorders.
- The several factors are included in the study which are impacting the market growth and restricting the market.
- This report consists of the segmentations and sub segmentations and the segment’s contribution to the market growth.
- The report further covers the profiles of the key vendors in market coupled with their strategies such as product launches, company expansions and acquisitions.
- Further, the report depicts the penetration of the market in the various regions.
Request Sample Report from here: https://www.marketresearchengine.com/olanzapine-market
TABLE OF CONTENTS
- Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO – Impact Analysis
5. Application: Market Size & Analysis
5.1. Overview
5.2. Bipolar Disorder
5.3. Others
5.4. Schizophrenia
6. Route of Administration: Market Size & Analysis
7. Distribution Channel: Market Size & Analysis
8. Geography: Market Size & Analysis - Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. Alkermes, Inc.
10.2. Sun Pharmaceutical Industries Limited
10.3. Teva Pharmaceutical Industries Limited
10.4. Aurobindo Pharma Ltd
10.5. Eli Lilly and Company
10.6. apotex inc.
10.7. Dr. Reddy’s Laboratories Ltd.
10.8. Torrent Group
10.9. Novartis AG
10.10. Viatris
11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. AbbreviationsAbout MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Other Related Market Research Reports:
Cluster Headache Market Future Scope (2024-2027): Key Factors, Status and Forecast
Immune Checkpoint Inhibitors Market Future Scope (2024-2027): Key Factors, Status and Forecast
Dystonia Drugs Market Future Scope (2024-2027): Key Factors, Status and Forecast
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: [email protected]
Phone: +1-855-984-1862
Country: United States
